Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outlook Therapeutics (OTLK) Interest Coverage Ratio (2016 - 2020)

Outlook Therapeutics (OTLK) has disclosed Interest Coverage Ratio for 6 consecutive years, with 26.78 as the latest value for Q2 2020.

  • On a quarterly basis, Interest Coverage Ratio fell 413.23% to 26.78 in Q2 2020 year-over-year; TTM through Jun 2025 was 104.41, a N/A change, with the full-year FY2024 number at 22.71, down 8.22% from a year prior.
  • Interest Coverage Ratio was 26.78 for Q2 2020 at Outlook Therapeutics, down from 9.72 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1.18 in Q3 2017 to a low of 73.56 in Q2 2016.
  • A 5-year average of 16.94 and a median of 8.28 in 2018 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: surged 94.29% in 2017, then plummeted 849.73% in 2018.
  • Outlook Therapeutics' Interest Coverage Ratio stood at 36.38 in 2016, then skyrocketed by 87.82% to 4.43 in 2017, then tumbled by 106.61% to 9.15 in 2018, then crashed by 49.63% to 13.69 in 2019, then crashed by 95.55% to 26.78 in 2020.
  • Per Business Quant, the three most recent readings for OTLK's Interest Coverage Ratio are 26.78 (Q2 2020), 9.72 (Q1 2020), and 13.69 (Q4 2019).